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Abstract
Non-coding RNAs (ncRNAs) are functional RNA molecules that are transcribed from mam-
malian genome but lack protein coding capacity. Nearly 80% of the human genome constitutes 
non-coding elements such as small non-coding RNAs, sncRNAs (miRNA, piRNA, SiRNA, 
SnRNA) and long non-coding RNAs, lncRNAs (linc RNA, NAT, eRNA, circ RNA, ceRNAs, 
PROMPTS). These ncRNAs have been extensively studied and are known to mediate the 
regulation of gene expression. In recent decades, lncRNAs have emerged as pivotal molecules 
that participate in the post-transcriptional regulation by acting as a signal, guide, scaffold and 
decoy molecules in addition to their role(s) in transcription. ncRNAs are known to play criti-
cal roles in defining DNA methylation patterns, imprinting as well as chromatin remodeling, 
thus having a substantial effect in epigenetic signaling. The expression of lncRNAs is regu-
lated in a tissue specific and developmental stage specific manner and their mis-regulation is 
often associated with tumorigenesis. Henceforth, this chapter focuses mainly on the role(s) of 
ncRNAs in transcriptional and post-transcriptional regulation and their relevance in cancers.
Keywords: lncRNAs, miRNAs, DNA methylation, epigenetic signaling, transcriptional 
regulation, cancer
1. Introduction
1.1. The incredible RNA molecules
According to “RNA world hypothesis”, early life was started with RNA molecules. Later 
with time, storage of information evolved to more stable DNA and RNA which emerged as a 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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messenger of stored information thereby completing the central dogma of life. Though 80% of 
the human genome is transcribed into RNA, majority of RNA lacks protein coding potential 
and referred as “non-coding RNA” (ncRNA). Further, genome sequencing technologies have 
revealed that the mammalian transcriptome is much more complex and their transcription is 
regulated by developmental stages [1]. The continuing discovery of new classes of regulatory 
ncRNAs suggests that RNA has continued to evolve along with proteins and DNA.
ncRNAs are divided into two major groups based on an arbitrary threshold of 200 nucleo-
tides (nt) namely short ncRNAs (sncRNA) and long ncRNAs (lncRNAs) (Figure 1). sncRNAs 
include functional RNAs such as t-RNAs, r-RNAs and snRNAs which are involved in tran-
scriptional and translational regulation. In addition to these conventional RNAs, short ncRNAs 
also include different regulatory RNAs such as microRNAs (miRNAs) [2, 3], small interfer-
ing RNAs (siRNAs) and P-element-induced wimpy testis (PIWI) interacting RNAs (piRNAs) 
[4], all of which regulate gene expression. In contrast to sncRNAs, the lncRNAs are a group 
of large, heterogeneous ncRNAs of unknown function. Similar to coding RNA transcripts, 
lncRNAs contains epigenetic marks indicating their ability to express differentially [5] and the 
presence of introns in lncRNAs emphasizes the existence of splice variants. These lncRNAs 
exist in both polyadenylated and non-polyadenylated forms and hence are termed “bimor-
phic” [6]. LncRNAs include many different types of RNA and exhibit a wide range of second-
ary and tertiary structures compared to the coding transcriptome. Some pseudogenes and 
Figure 1. Classification of non-coding RNA (ncRNA).
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copies of coding genes harboring mutations render lncRNAs non-coding [7]. Many lncRNAs 
are known to overlap coding genes [8]. A lncRNA might encompass either the entire gene or 
only a part of it and these lncRNA may originate from either the sense or antisense strand [9, 
10]. The lncRNAs were termed based on their mechanism of action, such as intergenic (lin-
cRNA), natural antisense transcripts (NATs), enhancer RNA (eRNA), circular RNA (circRNA), 
promoter associated long RNA (pRNA), etc. LncRNAs act at different levels of gene expression 
to exhibit diverse cellular functions. This functional diversity reflects the versatility of ncRNA 
and its interaction with a large number of substrates in a highly specific manner. Moreover, 
the expression of ncRNA is dynamic and can be rapidly up-regulated or down-regulated dur-
ing developmental stages or differentiation without being translated [11]. Henceforth, in this 
chapter, we will discuss mainly on the gene regulatory roles of lncRNAs and miRNAs in dis-
tinct cellular functions and developmental regulation.
2. The small non-coding RNAs (sncRNAs)
The sncRNAs are extensively studied in the last decade and have been associated with RNA 
interference (RNAi) pathways, which lead to silencing of specific genes and protection of the 
cell or genome against viruses, mobile repetitive DNA sequences, retro-elements and trans-
posons [12].
2.1. miRNAs and siRNAs
Both the siRNAs and miRNAs are 20–30 nucleotides long and generated from sense and anti-
sense DNA strands, pseudogenes and inverted repeats. These molecules induce mRNA deg-
radation or translational repression, which in turn result in the alteration of gene expression. 
About 60% of translated protein coding genes are negatively regulated by miRNAs [13]. Some 
transcripts are regulated by a single miRNA, while others are regulated by more than one 
miRNAs [14]. In addition to the transcriptional gene regulation, miRNAs play important roles 
in pivotal biological processes such as cell proliferation, cell differentiation, development, and 
cell death [15–18].
2.2. miRNA and siRNA biogenesis and mechanism of action
The process of miRNA biogenesis is quite characteristic for the ncRNAs subclass. Based on cellu-
lar requirement, the primary miRNA transcript (pri-miRNA) is first transcribed from the DNA 
by RNA polymerase II and characterized by one or many stem-loop hairpins which encom-
pass the functional mature miRNA in their stem. In animals, the first step occurs in nucleus, 
in which the pri-miRNA upon recognition by two nuclear enzymes, Drosha and DGCR8 is 
processed into dsRNA molecule containing one or more hairpins of approximately 70 nucleo-
tides long, which are called as precursor miRNAs (pre-miRNAs). Then they are exported to 
the cytoplasm by the nuclear export protein exportin-5 [19]. In cytoplasm, the pre-miRNA is 
recognized and processed by the RNase III enzyme, Dicer which removes the hairpin loop 
resulting in 20–23 nt dsRNA (miRNA-miRNA*) molecule. In case of siRNAs, the small RNA 
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duplex molecules produced by the action of Dicer, creates a RNA duplexes with 2-nt over-
hangs at their 3′ ends and phosphate groups at their 5′ ends [19]. Only one of the two strands 
of dsRNA acts as a guide strand and directs gene-silencing while, the other strand incorpo-
rates into the RNA-induced silencing complex (RISC) containing the Argonaute proteins 
(Ago1/2) and the GW182, where the anti-guide or passenger strand is degraded resulting in 
20–23 nt mature miRNA (Figure 2). The siRNAs are recognized by Argonaute protein 2 (Ago2) 
[18, 20], and the selection of the different Ago proteins are based on the small interfering 
RNA duplex structure. Generally, siRNAs that are perfect duplexes in terms of base pairing 
are loaded into Ago2, whereas duplexes presenting mismatches as in the case of miRNAs, 
are driven by Argonaute 1 (Ago1) [21, 22]. When the complementarity between the miRNA 
bound to Ago1 and the target m-RNA is high, miRNA tailing and 3′–5′ trimming occurs. The 
discrimination between Ago1 and Ago2 depends on the action of Hen1; an enzyme that adds 
the 2′-O-methyl group at the 3′ ends of small RNAs bound to Ago2, but not those bound to 
Ago1 [23]. This methyl group is known to block tailing and trimming of the miRNA. The RISC 
complex then targets the mRNA transcript based on sequence complementarity between the 
Figure 2. Biogenesis of miRNA and its mechanism of action (modified from Hrdlickova B et al. [18]).
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miRNA sequence and nucleotides in the 3′ untranslated regions (3′ UTR) of the target mRNAs 
[24]. The binding of the RISC complex to its target leads to direct Ago-mediated cleavage of the 
target and causes mRNA degradation if the homology between miRNA and its target mRNA 
is extensive or to deadenylation followed by translation prevention if the homology between 
the miRNA and its target is less extensive [20, 25]. Efficient targeting requires continuous base 
pairing of the miRNA seed region (which is a stretch of 6–8 nucleotides of the mature miRNA) 
with its target mRNA [25, 26]. Unlike miRNA, siRNA base pairs perfectly and induce mRNA 
cleavage only in a single specific target. Initially, it has been showed that miRNAs mainly tar-
get the 3′ UTRs of mRNAs [20], but recently, it was found that miRNA target sites also been 
located in the 5′ UTRs and even in coding regions of some of the target mRNAs [20, 27]. For 
example, mir-148 targets on the coding regions of DNMT3B.
2.3. Role of miRNA in cancer and diseases
miRNAs have been shown to be involved in several human diseases including cancer, neu-
rodegenerative, cardiovascular and autoimmune diseases [14]. Differential expression of spe-
cific miRNA will result in the up-regulation or down-regulation of their targets leading to the 
deregulation of cellular pathways.
In human diseases, expression of miRNAs could be differentially regulated by:
i. Altered functions of the enzymes involved in the miRNA biogenesis pathway. For exam-
ple, DiGeorge syndrome results due to haploinsufficiency of DGCR8 [18].
ii. Transcriptional repression of miRNAs by promoter hypermethylation [28]. For example, 
the miR-200 family is involved in the control of the epithelial-mesenchymal transition 
(EMT) [18].
iii. Genetic alterations in miRNA genes or in their regulatory motifs which can have del-
eterious consequences [29]. The deletion of chromosome 13q14 in chronic lymphocytic 
leukemia (CLL) patients is the best studied example in which the deleted area contains 
the miR-15a and miR-16-1 genes that target the anti-apoptotic/pro-survival gene BCL-2 
(B-cell lymphoma 2) and thus deletion of this region contributes to the greater survival 
of cancerous cells [18].
3. The long non-coding RNAs (lncRNAs)
LncRNAs are defined as a heterogeneous group of transcripts that are >200 nucleotides (nt) 
in length. These lncRNAs do not exhibit coding potential [30–32] and are transcribed from 
DNA. These lncRNAs can be intergenic, exonic, in enhancer regions or in the regions distal 
to protein-coding genes [11, 33]. Like mRNAs, lncRNAs are transcribed by RNA polymerase 
II (RNA PolII) and undergo post-transcriptional processing such as alternative splicing, 5′ 
capping, polyadenylation and RNA editing and also carry single nucleotide polymorphisms 
(SNPs) [31, 34].
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In comparison to protein coding RNAs, lncRNAs have few, but longer exons [30, 35]. 
Other characteristics of lncRNAs include: (i) well conserved lncRNA promoter regions 
between vertebrates; (ii) unique promoters, DNA-binding motifs and preferred transcrip-
tion factors (TFs), (iii) less conserved lncRNA exons between species and (iv) tissue spe-
cific expression profiles [5, 31, 36–38]. Compared with protein coding genes, only 11–29% 
of lncRNAs are ubiquitously expressed in all tissues and they are expressed at very mini-
mum levels [31, 39]. Computational analysis of RNA-Seq data has suggested that lncRNA 
transcription is independent and influence the transcription of neighboring protein cod-
ing genes [31, 38]. The origin of lncRNAs is still under debate. A recent study [40], has 
reported that more than two-thirds of mature lncRNA transcripts contain transposable 
elements (TEs). This observation has led to the postulation that the majority of lncRNAs 
might have arisen via insertion of TEs [41].
3.1. Classification of lncRNAs
LncRNAs have been classified based on their: (i) genomic location, (ii) mechanism of action, 
and (iii) effects on DNA sequences.
3.1.1. Classification of lncRNAs based on genomic location
LncRNAs could be classified into four broad categories based on their relative position to 
the nearest protein coding genes (Figure 3). The first class is the “long intergenic non-coding 
RNAs” (lincRNAs) which is the largest group of lncRNAs and these genes do not overlap 
or lie in close proximity to protein coding genes [5, 42]. The second most prevalent class of 
lncRNA is the “antisense lncRNA” that is transcribed from the antisense strand and are over-
lapping. Based on their overlap, the antisense lncRNAs are subdivided into two:(i) “intronic 
antisense lncRNAs” where the lncRNA transcript falls completely within the boundaries of 
an opposing intron, and (ii) “natural antisense transcripts” (NATs) which partially overlaps 
around the promoter or at the terminator site of the coding gene [43, 44]. The third class of 
lncRNAs comprises the “sense lncRNA” transcripts which can be “sense intronic or “sense 
overlapping.” Such transcripts are located on the same strand and transcribed in the same 
direction as a protein coding gene. The fourth class of lncRNAs is the “bidirectional lncRNAs” 
or “divergent lncRNAs.” These transcripts are located on the antisense strand and have their 
transcription start site (TSS) close to the TSS of the protein-coding gene, but are transcribed in 
the opposite direction [45–47].
3.1.2. Classification of lncRNAs based on their mechanism of action
LncRNAs can interact with DNA, RNA as well as proteins. LncRNAs have been implicated 
mainly in post-transcriptional gene regulation by controlling processes like protein synthe-
sis, RNA sequestration, RNA transport and have been shown to control transcriptional gene 
silencing via epigenetic regulation and chromatin remodeling [48, 49]. LncRNAs are divided 
into four archetypes based on their molecular mechanism (Figure 4) [18]. LncRNAs that 
belongs to the “signaling archetype” acts as a molecular signal for a particular biological 
condition and may activate or silence the genes depending on the stimulus (Figure 4A). 
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Some of the examples of lncRNAs displaying the signaling archetype are lncRNAs involved 
in embryonic development (HOTAIR and HOTTIP), DNA damage response (lincRNA-p21 
and PANDA), stress responses (COLDAIR and COOLAIR), etc. [18]. The second category is 
the “decoy archetype” where the lncRNAs act as decoys that bind to and interfere with the 
function of other RNAs or proteins. They act by competing with their sequences or structures 
for binding and are considered to be negative regulators (Figure 4B). For example, PANDA 
binds to the transcription factor NF-YA and prevents the activation of NF-YA induced pro-
apoptotic targets [18]. The “guide archetype” is the third class, in which the lncRNAs binds 
to specific proteins and transport them to the specific targets. The interaction may be direct 
(between lncRNA-protein complex and the DNA) or indirect (between lncRNA-protein and 
protein-DNA complexes) (Figure 4C). These lncRNAs may interact as activators or repres-
sors with neighboring (cis-acting) or distant (trans-acting) genes. Examples of lncRNAs 
employing this mechanism are HOTAIR, lincRNAp21, Xist, COLDAIR and Jpx (just proxi-
mal to XIST). The fourth archetype is “scaffold archetype” (Figure 4D), where the lncRNAs 
act by bringing the bound proteins into a complex or in spatial proximity. Examples of this 
lncRNAs are ANRIL (antisense ncRNA in the INK4 locus) which functions as a scaffold for 
the chromatin remodeling complexes PRC1 and PRC2, HOTAIR (scaffold for PRC2 binding 
it to the LSD1 complex) and TERC (telomerase RNA component) that scaffolds the telomer-
ase complex [18].
Figure 3. Classification of lncRNAs based on position relative to the nearest protein coding gene (modified from 
Hrdlickova B et al. [18]).
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3.1.3. Classification of lncRNAs based on their effects on DNA sequence
LncRNAs could be divided into “cis-acting” and “trans-acting” based on the effects exerted 
on DNA sequences. The effects of cis-acting lncRNAs are restricted to genes in close genomic 
proximity (usually the genes in the chromosome from which they are transcribed from), 
whereas trans-acting lncRNAs affect distant genes (the genes on other chromosomes) [50]. 
The action of both cis and trans lncRNAs is locus specific and in both cases, the lncRNA binds 
epigenetic modifiers through a specific sequence or structure and targets them to promoter 
regions to regulate the expression of respective genes. For example, HOTTIP and HOTAIR 
lncRNAs [51]. The major example of general cis-regulation is induction of X inactivation by 
the Xist lncRNA in female mammals. Xist is expressed from one of the two X chromosomes 
and induces silencing of the whole chromosome [50]. Example of trans-regulation is the B2 
lncRNA that binds to RNA PolII and inhibits phosphorylation of its carboxy-terminal domain 
(CTD), thus affecting RNA polymerase reaction [50].
4. Gene regulation by lncRNAs
LncRNAs have diverse regulatory functions and might regulate gene expression by modulating 
chromatin remodeling, cis and trans gene expression, gene transcription, post-transcriptional 
Figure 4. Classification of lncRNAs based on the mechanism of action.
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regulation, translation, protein trafficking and cellular signaling [33, 34]. Growing number of 
evidences implicate lncRNAs in transcriptional gene regulation, thereby suggesting a signifi-
cant role(s) for lncRNAs in such tightly regulated process [52, 53]. The mechanisms of transcrip-
tional and post-transcriptional regulation by lncRNAs is discussed below.
4.1. Transcriptional regulation
Regulation of transcription is considered to be an interplay of transcription factors (TFs) and 
chromatin modifying factors at the gene promoters. LncRNAs modulate gene expression by 
specifically associating with other molecules; DNA, RNA and protein, either at the promoters 
or at the enhancers of their target genes. LncRNAs regulate transcription by various mecha-
nisms and some are shown below.
4.1.1. Enhancer RNAs
Enhancer RNAs (eRNAs) are a category of lncRNAs derived from enhancer regions of genes, 
which interact with DNA to upregulate gene transcription through two possible mechanisms 
such as enhancer-promoter looping and tracking of transcriptional machinery [54]. While 
studying the enhancers activated by calcium signaling in mouse neurons, Kim et al. for the 
first time, identified a eRNA of about 2 kb transcribed bidirectionally from active enhanc-
ers. The expression of this eRNA correlated with the activity of the enhancer region [55, 56], 
which suggests that eRNAs contribute to enhancer function and influence the transcription 
of genes.
4.1.2. Activating ncRNAs
Activating ncRNAs are a class of lncRNAs which are transcribed from independent loci, but 
not from enhancers and have a transcriptional activation function [57, 58]. Activating ncRNAs 
specifically activate the transcription of neighboring coding genes in an RNA-dependent fash-
ion, and require the activity of the coding gene promoter [58]. These activating ncRNAs are 
functionally similar to eRNAs. However, in contrast to eRNAs, activating ncRNAs are spliced, 
polyadenylated stable transcripts. Gene activation mediated by the activating ncRNAs requires 
a change in chromosomal conformation to bring the activating ncRNAs locus close to the pro-
moter of its target gene [59]. A number of activating ncRNAs have been shown to be associ-
ated with the mediator complex which is involved in bridging promoters with enhancers; 
and depletion of this complex inhibits looping between the activating ncRNAs locus and its 
target gene. Thus, eRNA and activating ncRNAs function by interacting with the same set of 
molecules, forming a scaffold for a protein complex that bridges the enhancer-like element 
and the promoter of a coding gene (Figure 5) [60].
4.1.3. Transcriptional regulation by recruitment of chromatin modifiers
As discussed earlier in this chapter, lncRNAs mediate epigenetic changes by DNA methylation, 
histone modification and by recruiting chromatin remodeling complexes to specific genomic 
loci mainly to the promoter regions and causes repression or activation of the target genes. It 
Roles of Non-Coding RNAs in Transcriptional Regulation
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was found that the lncRNA might serve two functions. (i) lncRNAs act as a bridging scaffold 
and binds to a protein or protein complex to facilitate chromatin conformational changes [61]. 
(ii) lncRNAs act as tethered scaffold that targets chromatin modifying enzymes to specific DNA 
motifs (Figure 5). For example, the lncRNA HOTAIR (Hox transcript antisense RNA) acts as an 
epigenetic-protein scaffold and possess multiple binding domains for distinct proteins. At the 
3′ end, HOTAIR contributes to the demethylation of H3K4 by interacting with lysine-specific 
histone demethylase 1A (LSD1), restrictive element 1-silencing transcription factor (REST), and 
REST corepressor1. At the 5′ end, HOTAIR originated from the HOXC locus and causes tran-
scriptional gene silencing across 40 kb of the HOXD locus in trans by inducing a repressive 
chromatin state, by recruitment of the Polycomb chromatin remodeling complex PRC2 and 
reinforcing H3K27 methylation [34, 62].
4.1.4. Genomic imprinting and X-chromosome inactivation
Genomic imprinting is the phenomenon of epigenetic silencing of an allele inherited from 
either of the parents [63]. Imprinting Control Regions (ICRs) are short stretches of DNA that 
play a critical role in imprinting of multiple genes [64]. Interestingly, it has been observed 
that the imprinted regions show significant association with ncRNAs, which mediate the 
silencing by diverse mechanisms like chromatin remodeling and enhancer competition 
[65]. X chromosome inactivation is a process mediated by the long ncRNA- Xist, in which 
one copy of the X chromosome in females is inactivated. From the Xist locus, a small inter-
nal non-coding transcript RepA recruits PRC2 to silence one X chromosome [61]; whereas 
PRC2 is formed from the remaining active X chromosome by the antisense transcript Tsix. 
However, an alternative mechanism is described by another study in which Xist and Tsix 
anneal to form an RNA duplex that is processed by Dicer to generate small interfering RNAs 
(siRNAs) which are required for the repressive chromatin modifications on the inactive X 
chromosome [1].
4.2. Post-transcriptional regulation
At post-transcriptional level, lncRNAs regulate by acting as competing endogenous RNAs 
that regulate microRNA levels which in turn modulate mRNA levels by altering mRNA sta-
bility, mRNA decay, and translation [66].
Figure 5. Models of transcriptional regulation. (A) Bridging scaffold model: lncRNAs (red line) transcribed from 
enhancer-like non-coding genes are required to recruit the mediator complex. (B) Tethered scaffold model: lncRNA (red 
line) recognizes specific DNA motifs and recruits histone modifying enzymes.
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4.2.1. LncRNA as a source of miRNA
Most pri-miRNAs are generally greater than 1 kb in length [67]; and therefore may be regarded 
as a form of lncRNA. There are two major sources of pri-miRNAs in the genome: (i) pri-miR-
NAs that are embedded within another gene and whose expression is usually but not always 
linked to the expression of the parent transcript, and (ii) pri-miRNAs that are transcribed inde-
pendently from miRNA genes which contain promoters that regulate their transcription mainly 
by RNA polymerase II (RNA PolII) in a manner similar to mRNA [66]. Approximately 50% of 
miRNAs are produced from non-coding transcripts [68]; however, with miRNAs embedded in 
coding genes many miRNAs are also located within introns of non-coding genes (Figure 6) [66]. 
Such a genomic organization suggests that the host lncRNA does not simply act as a pri-miRNA 
but may have other additional roles encoded by the exons. For example, DLEU2 is the host gene 
of the tumor suppressor miRNA, miR-15a/16.1 cluster located within its third intron [66].
4.2.2. LncRNA as a negative regulator of miRNA
miRNAs are known to act as negative regulators of gene expression. Transcripts are targeted 
through binding of a short 6–8 nt seed sequence within the miRNA to a miRNA response ele-
ment (MRE) in the 3′ UTR regions of targets. Computational predictions based on miRNA seed 
sequences found that many lncRNAs contain miRNA binding sites. This raises an interesting 
possibility that many lncRNAs function to regulate gene expression by sequestering miRNAs, 
thus limiting their concentration within the cell and thereby reducing the pool of available 
miRNA in the cell. In this way, the lncRNA acts as a negative regulator of miRNA function 
and thereby a positive regulator of gene expression. This is known as the “competing endoge-
nous RNA (ceRNA)” hypothesis (Figure 7) [69, 70]. For example, the intergenic lincRNA-ROR, 
which inhibits miR-145 in pluripotent embryonic stem cells [66]. Competitive endogenous 
RNAs (ceRNAs) are lncRNAs that sequester miRNAs and inhibit miRNA functions and have 
two structurally distinct forms such as linear and circular. Non-circular or linear lncRNAs are 
single-stranded molecules that bind to miRNAs and regulate gene expression by promoting it 
to degradation [71]. Circular RNAs (circRNAs) are a type of ring-forming lncRNA that form 
Figure 6. LncRNA as a source of miRNA. LncRNA genes contain embedded miRNA sequences (red hexagonal boxes) 
which may be located within an exon (orange box) or an intron (line) or occur in clusters within the genome. Though 
the sources are different, the pathways converge at the level of pre-miRNA structure which produce miRNA (modified 
from Dykes IM et al. [66]).
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by linking the 3′ and 5′ ends with a back splicing covalent bond [72, 73]. In addition, lncRNAs 
can facilitate the inhibition of mRNA translation or decay by partial base pairing with the 3′ 
UTR sequences through their Alu elements in Staufen-mediated manner [74]. A non-coding 
transcript that shares a high degree of homology with a coding gene is likely to share many 
of its MREs and therefore pseudogenes are considered as good candidates to act as ceRNAs 
[7, 75, 76]. Example of such lncRNA include a pseudogene homologous to the gene encoding 
tumor suppressor phosphatase and tensin homolog (PTEN), which contains multiple MREs 
with in the 3′ UTR shared with the coding gene [76].
4.2.3. LncRNA-mediated and miRNA-independent mRNA degradation
In addition to regulating gene expression through interaction with miRNAs, some lncRNAs 
directly targets mRNA for degradation. For example, Staufen 1 (STAU1) is a protein that rec-
ognizes a specific motif in the 3′ UTR of mRNAs and mediates their degradation by nonsense 
mediated mRNA decay (NMD) [77]. STAU1 binds to a double-stranded RNA motif within 
the 3′ UTR of the mRNA encoding ADP-ribosylation factor 1 (ARF1), where it forms a stem 
loop structure. However, some mRNAs targeted by Staufen-mediated decay, lacks the stem 
loop structure and contains only a single stranded binding site within the 3′ UTR, e.g., serpin 
peptidase inhibitor-clade E member1 (SERPINE1). Interestingly, such mRNAs are targeted by 
a lncRNA carrying a complementary single stranded binding site and imperfect binding of 
lncRNA to the mRNA create a double-stranded RNA binding motif for STAU1. This class of 
lncRNAs are called as half STAU1 binding site RNAs [74].
Figure 7. The ceRNA hypothesis. miRNA binds to identical MREs (hexagonal) which are usually present in a number 
of ncRNA species such as pseudogenes, circRNAs and other forms of lncRNAs and independently transcribed mRNA 
3’UTRs. All of these RNAs compete for a limited pool of miRNA, thus positively regulating gene expression.
Transcriptional and Post-transcriptional Regulation66
5. Roles of LncRNA in diseases
5.1. LncRNAs and aging
Aging is a complex physiological phenomenon with a progressive decline in functional capaci-
ties and environmental adaptations. The expression of lncRNAs is known to be affected during 
aging process and in turn, many lncRNAs govern major senescent pathways and senescence-
associated secretory phenotype [78–80]. In human fibroblasts, senescence-associated lncRNA-
SAL-RNA1 delays senescence and reduced levels of this lncRNA enhances senescence traits 
such as enlarged morphology, increased p53 levels and positive β-galactosidase activity [81]. 
Another example is the lncRNA MIR31HG, which is upregulated in oncogene-induced senes-
cence, and its knockdown promotes a strong tumor-suppressor p16-dependent senescence 
phenotype [82].
5.2. LncRNAs in cancer and other diseases
Altered lncRNA function is identified as one of the causes for the dysregulation of gene 
expression which leads to several human diseases including cancer. One such lncRNA is 
MALAT1 also known as NEAT2, (nuclear-enriched abundant transcript2) which was identi-
fied as a predictive biomarker for metastasis development in lung cancer [83, 84]. It acts by 
inducing the expression of metastasis-associated genes [85]; and recently it was shown that 
in vitro metastasis of EBC-1 cells (human lung cancer cells) can be inhibited by antisense 
oligonucleotides directed to MALAT1 [85, 86]. Another example is lncRNA HOTAIR that 
interacts with PRC2 and alters chromatin to a metastasis-promoting state [87]; and causes 
cancers such as breast, colon, colorectal, gastrointestinal, pancreatic and liver cancer [88–91]. 
The lncRNAs αHIF (antisense to hypoxia inducible factor α (HIFα)) and tie-1AS (tyrosine 
kinase containing immunoglobulin and epidermal growth factor homology domain-1 anti-
sense) are known to induce angiogenesis [42, 92]. PCGEM1 (prostate-specific transcript 1), 
UCA1 (urothelial cancer associated 1), SPRY4-IT1 (SPRY4 intronic transcript 1) and PANDA 
are involved in suppressing apoptosis [93–95]. LncRNAs also have roles in other diseases 
like neurogenetic Angelman syndrome and Beckwith-Wiedemann syndrome (BWS) [96]. 
LncRNAs have also been associated with cardiovascular diseases and other neurological dis-
orders such as BACE1-AS or BC200 in Alzheimer disease, HAR1 (human accelerated region 
1 lncRNA) in Huntington disease and ATXN8OS (Ataxin8 opposite strand lncRNA) in spino-
cerebellar ataxia type 8 [96–98].
6. Conclusion
The highly diverse biological functions of lncRNAs reflect the versatility of RNA molecules 
in the cell. Studies on different classes of ncRNAs, their biogenesis and functional overlaps 
suggest their complexity and their ability to operate as an integrated and regulated network. 
In this chapter, we have highlighted different mechanisms of regulation of gene expression 
by lncRNAs at transcriptional and post-transcriptional level by their ability to interact with 
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enhancers, promoters, chromatin-modifying complexes and miRNAs. Due to environmental 
exposures, genetic mutations and other causes, deregulation of lncRNAs are associated with 
various human diseases such as cancer, neurological disorders like Alzheimer’s disease, car-
diovascular diseases, and autoimmune diseases. This chapter along with recent evidences 
emphasizes the significance of lncRNA as novel therapeutic targets in aging and aging-related 
human diseases.
7. Future perspectives
Mounting evidences suggest significant roles of ncRNAs in physiological and pathological 
processes, which have expanded our basic understanding of gene expression. However, on 
the other hand, we have also realized the increasing complexity in the structure and organi-
zation of genome and gene networks. Recently, our laboratory identified a novel non-coding 
RNA of DNMT3B variant (DNMT3B9) from leukemic cell lines and the exact roles in hemato-
poiesis study is underway. This chapter recommends future research on the structural motifs 
and gene regulatory network of ncRNAs and their stability and degradation process, which 
we believe will expand the horizons of ncRNAs biology to establish potential diagnostic and 
therapeutic strategies in this field. Another challenging avenue is to explore the mechanisms 
underlying the functions of ncRNAs, which still remain elusive. Also, studies on the interplay 
between various ncRNAs might shed light on the usage of ncRNAs as potential biomark-
ers for early detection and improve the treatment of various diseases including cancer. With 
increasing discovery of ncRNAs and advancing technologies, ncRNA based therapies would 
be an effective health-care strategy.
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